348
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Non-Normal Random Effects Models for Immunogenicity Assay Cut Point Determination

, , , , &
Pages 295-306 | Received 29 Sep 2014, Accepted 30 Sep 2014, Published online: 25 Feb 2015

REFERENCES

  • Azzalini, A., Capitanio, A. (2003). Distributions generated by perturbation of symmetry with emphasis on a multivariate skew t-distribution. Journal of Royal Statistical Society, Series B: Statistical Methodology 65:367–389.
  • Claeskens, G., Hart, J. D. (2009). Goodness-of-fit tests in mixed models. Test 18:231–239.
  • Food and Drug Administration (2009). Guidance for Industry: Assay Development for Immunogenicity Testing of Therapeutic Proteins. Rockville, MD: U.S. Food and Drug Administration.
  • Heidelberger, P., Welch, P. D. (1983). Simulation run length control in the presence of an initial transient. Operations Research 31:1109–1144.
  • Hoffman, D., Berger, M. (2011). Statistical considerations for calculations of immunogenicity screening assay cut points. Journal Immunological Methods 373:200–208.
  • Jaki, T., Lawo, J., Wolfsegger, M. J., Singer, J., Allacher, P., Horling, F. (2011). A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays. Journal of Pharmaceutical and Biomedical Analysis 55:1148–1156.
  • Jara, A., Quintana, F., San Martn, E. (2008). Linear mixed models with skew-elliptical distributions: a Bayesian approach. Computational Statistics and Data Analysis 52:5033–5045.
  • Johnson, N. L., Kotz, S., Balakrishnan, N. (1994). Continuous Univariate Distributions, Vol. 2. 2nd ed. New York: John Wiley & Sons.
  • Kubiak R. J., Zhang, L., Zhang, J., et al. (2013). Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays. Journal of Pharmaceutical and Biomedical Analysis 74:235–245.
  • Lange, K. L., Little, R. J., Taylor, J. M. (1989). Robust statistical modeling using the t distribution. Journal of the American Statistical Association 84:881–896.
  • Lawless, J. F. (1980). Inference in the generalized gamma and log-gamma distribution. Technometrics 22:67–82.
  • Lawless, J. F. (1982). Statistical Models and Methods for Lifetime Data, New York: John Wiley & Sons.
  • Pinheiro, J. C., Liu, C., Wu, Y. (2001). Efficient algorithms for robust estimation in linear mixed-effects models using the multivariate t distribution. Journal of Computational and Graphical Statistics 10:249–276.
  • Prentice, R. L. (1974). A log gamma model and its maximum likelihood estimation. Biometrika 61:539–544.
  • Sahu, S. K., Dey, D. K., Branco, M. D. (2003). A new class of multivariate skew distributions with application to Bayesian regression models. Canadian Journal of Statistics 31:129–150.
  • Schlain, B., Amaravadi, L., Donley, J., Wickramasekera, A., Bennett, D., Subramanyam, M. (2010). A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution. Journal of Immunology Methods 352:161–168.
  • Shankar, G., Devanarayan, V., Amaravadi, L., Barrett, Y. C., Bowsher, R., Finco-Kent, D., Fiscella, M., Gorovits, B., Kirschner, S., Moxness, M., Parish, T., Quarmby, V., Smith, H., Smith, W., Zuckerman, L. A., Koren, E. (2008). Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. Journal of Pharmarceutical and Biomedical Analysis 48:1267.
  • Tovey, M. G. (2011). Detection and Quantifìcation of Antibodies to Biopharmaceuticals: Practical and Applied Consideration. New York: John Wiley & Sons.
  • Yu, B., O’Malley, A. J., Ghosh, P. (2012). Linear mixed models for multiple outcomes using extended multivariate skew-t distributions. Statistical and Its Inference In Press.
  • Zhang, L., Zhang, J., Kubiak, R. J., Yang, H. (2013). Statistical methods and tool for cut point analysis in immunogenicity assays. Journal of Immunological Methods 389:79–97.
  • Zhang, P., Song, P., Qu, A., Green, T. (2008). Efficient estimation for patient-specific rates of disease progression using non-normal linear mixed models. Biometrics 64:29–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.